{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Chicago plans to shut down six of its 12 mental health centers by the end of April, leaving many patients without adequate treatment and potentially driving up prison populations.", "headline": {"seo": "In Chicago, Mental Health Patients Have No Place to Go", "main": "Psychiatric Patients With No Place to Go but Jail", "print_headline": "Psychiatric Patients With No Place to Go but Jail", "content_kicker": "Chicago News Cooperative"}, "abstract": null, "print_page": "25A", "word_count": "1106", "_id": "53f3b80179881034aaf5ab2e", "snippet": "Chicago plans to shut down six of its 12 mental health centers by the end of April, leaving many patients without adequate treatment and potentially driving up prison populations.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/02/19/health/in-chicago-mental-health-patients-have-no-place-to-go.html", "multimedia": [{"subtype": "xlarge", "url": "images/2012/02/19/us/19CNCDART1/19CNCDART1-articleLarge.jpg", "height": 401, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2012/02/19/us/19CNCDART1/19CNCDART1-articleLarge.jpg", "xlargeheight": "401"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/02/19/us/19CNCDART1/19CNCDART1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/02/19/us/19CNCDART1/19CNCDART1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Mental Health and Disorders", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Shutdowns (Institutional)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Prisons and Prisoners", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Chicago (Ill)", "is_major": "N", "rank": "4", "name": "glocations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Bridget", "lastname": "O'SHEA"}], "original": "By BRIDGET O'SHEA"}, "document_type": "article", "pub_date": "2012-02-19T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The Food and Drug Administration said it was worried about possible heart problems and birth defects with Qnexa, a weight-loss drug.", "headline": {"seo": "F.D.A. Still Wary of Diet Pill&#8217;s Side Effects", "main": "Side Effects of Diet Pill Still Concern Regulators", "print_headline": "Side Effects Of Diet Pill Still Concern Regulators"}, "abstract": "Food and Drug Administration says it is worried about possible heart problems and birth defects with Qnexa, a weight-loss drug; committee of advisers to the FDA will consider again whether the drug, developed by Vivus, should be approved.", "print_page": "1", "word_count": "826", "_id": "515b6fe1fdc59278db00a426", "snippet": "The Food and Drug Administration said it was worried about possible heart problems and birth defects with Qnexa, a weight-loss drug.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/02/18/health/fda-still-wary-of-diet-pills-side-effects.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Vivus Inc", "is_major": "Y", "rank": "3", "name": "organizations"}, {"value": "Obesity", "is_major": "Y", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2012-02-18T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The Food and Drug Administration will review a new diet pill consisting of a combination of two pills people are using in California to lose weight.", "headline": {"seo": "Diet Treatment, Already in Use, to Get F.D.A. Review", "main": "U.S. to Review Diet Treatment Once Rejected", "print_headline": "U.S. to Review Diet Treatment Once Rejected"}, "abstract": "Food and Drug Administration will review a new diet pill consisting of a combination of two pills people are using in California to lose weight; the pill, Qnexa, was rejected by the FDA in 2010 amid safety concerns, but the manufacturer, Vivus, is presenting additional data to argue its case; doctors are allowed to prescribe the two approved components off-label as they see fit, which, taken together, are essentially the same medicine.", "print_page": "1", "word_count": "1432", "_id": "515b7006fdc59278db00a457", "snippet": "The Food and Drug Administration will review a new diet pill consisting of a combination of two pills people are using in California to lose weight.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2012/02/17/business/diet-treatment-already-in-use-to-get-fda-review.html", "multimedia": [{"subtype": "xlarge", "url": "images/2012/02/17/business/OBESITYCITY/OBESITYCITY-articleLarge.jpg", "height": 330, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2012/02/17/business/OBESITYCITY/OBESITYCITY-articleLarge.jpg", "xlargeheight": "330"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2012/02/17/business/OBESITYCITY/OBESITYCITY-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2012/02/17/business/OBESITYCITY/OBESITYCITY-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Obesity", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Najarian, Thomas", "is_major": "N", "rank": "3", "name": "persons"}, {"value": "Vivus Inc", "is_major": "Y", "rank": "4", "name": "organizations"}, {"value": "Inventions and Patents", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2012-02-17T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 3, "offset": 0, "time": 46}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}